Drug safety sciences and the bottleneck in drug development

During a recent review of a new drug application for treatment of a chronic disease, US Food and Drug Administration (FDA) regulators agreed with the sponsor's assessment of efficacy. However, it was noted that two subjects receiving active treatment experienced abnormal liver chemistries that...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics Vol. 89; no. 6; p. 788
Main Author: Watkins, P B
Format: Journal Article
Language:English
Published: United States 01.06.2011
Subjects:
ISSN:1532-6535, 1532-6535
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first